Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
made me laugh
still holding GLTA
I am holding as well....
Nobody's selling down here, at least not me!
Can you streeetch it to .0016? LOL
Unless there is some big news coming out, this stock wont see past what we recently hit at .0012.
... at .01 it would have a 15 million dollar market cap, and thats if there is only 1.5 billion shares outstanding.
We need PR to push this into penny land, hope we will get soon
Well interesting post Toucan
Something big is going on ,
Joe Overcash "used" to own MMTE... and still owns PMDP why sell if they would merge? lol
I opinion is that MMTE & PMDP Will Merge together!
Somebody is telling other day that A/S has been increased to 5B
stock was up almost 100% today....
I guess you were still waiting to buy
Greed is good
(gordon gecko)
tommer
Pinksheets.com : Estimated Market Cap
$449,607 as of Oct 27, 2009
lol very low OS
I believe we will see .00's
Very Low O/S:
Estimated Market Cap
$449,607 as of Oct 27, 2009
Outstanding Shares
1,498,691,168 as of Sep 4, 2009
Authorized Shares
1,500,000,000 as of Sep 4, 2009
Float(shares)
1,498,181,549 as of Sep 4, 2009
Number of Shareholders of Record
1,516 as of Sep 4, 2009
Link: http://www.pinksheets.com/pink/quote/quote.jsp?symbol=mmte
Link: http://investorshub.advfn.com/boards/board.aspx?board_id=10868&NextStart=12336
I do not think the MMS have many shares!
well scary short maybe
Not getting filled either!
Crook mm they pass order at 5 when demand 6
mines been locked at .01
do not put AON....
why they dont take buy order at 6
Did Everyone Lock There Sell Orders At .02+?
Hit the Ask!
MM weird I want to buy at 6 MM show 5
lol ....ummmmm no
How many do you have?
well I have more than you ah ah
she is sore but she liked a good spanking....
she invites new buyers to slap her ask~
before close hehe
tommer
I wonder if
Oklahoma City, OK and Houston, TX, – Chesapeake Energy Corporation (NYSE:CHK) and BP America Inc. (NYSE:BP) today announced that BP has agreed to acquire all of Chesapeake’s interests in approximately 90,000 net acres of leasehold and producing natural gas properties in the Arkoma Basin Woodford Shale play for $1.75 billion in cash.
I am buying another 10M+
64M In Volume!
a 50M share buying surge is no false alarm lol
Lets go guys, lets slap the ask
ask running low on inv....slap her she likey
tommer
I see 00's tomorrow
Better get the 5's before there gone!
Backup she goes!
EXPECT A ROCKETSHIP TOMORROW
TOMMER
I am sure it one someone that paid .0003 took a profit....Not worried...
Back down she goes. Must have been a false alarm
well nice volume, will gap tommorrow
lets close above
Need to hit the ask
amazing buying today.
Glad to have you aboard!
Medical product development and commercialization. The Company recently acquired five generic oncology drugs approved and manufactured in Germany and they plan to gain approval for these drugs in the US in 2023. The Company is preparing for a pivotal Phase 3 study of an anti-cancer antibody product that is highly similar to Genentech/Roche's brand name Avastin (bevacizumab), the Company has licensed a needle-free jet injector for drug delivery, and the Company is in the pre-clinical stages of development of a gene therapy product candidate based on the delivery of a human alpha-Klotho gene and protein to prevent and/or treat neurodegenerative diseases such as Alzheimer's and Lou Gehrig's disease (ALS). Other product candidates will stem from these platform technologies of pharmaceuticals, biologics, and gene therapy.
The Company's medical R&D facilities are in the U.S. (near the University of Nebraska Medical Center, Omaha, Nebraska) and in Barcelona, Spain (Autonomous Universitat de Barcelona). Each R&D facility is comprised of over 4,000 sq ft of R&D and office space, currently leased and equipped with research equipment, incubators, tissue culture facilities for production of plasmid DNA, HEPA-filtered hoods for aseptic handling, and testing equipment (PCR, spectrophotometers, microscopes, etc). The generic oncology drugs are manufactured in Germany. With future funding, the Company plans to acquire or build a GMP manufacturing facility to supply novel plasmid DNA ("transgenes") to be used in gene therapy programs, to provide contract manufacturing revenue, and for commercial product manufacturing.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |